AI-powered search
Try Polaris, our new AI-powered search!

When changing from an IL-17 to an IL-23 or vice versa, how long do you typically wait before initiating a new drug?

Featuring Benjamin Lockshin, MD |

EVP of Strategic Initiatives
Director of the Clinical Trials Center
Assistant Professor
US Dermatology Partners
Georgetown University
Rockville, MD

| Published July 12, 2022